Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Change in Account Payables (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Change in Account Payables for 4 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 1017.48% to -$1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50000.0 through Dec 2025, up 101.09% year-over-year, with the annual reading at $50000.0 for FY2025, 101.09% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$1.3 million at Centessa Pharmaceuticals, down from $3.3 million in the prior quarter.
  • The five-year high for Change in Account Payables was $3.3 million in Q3 2025, with the low at -$4.2 million in Q1 2024.
  • Average Change in Account Payables over 4 years is -$56625.0, with a median of $113000.0 recorded in 2023.
  • The sharpest move saw Change in Account Payables skyrocketed 1955.42% in 2024, then crashed 1017.48% in 2025.
  • Over 4 years, Change in Account Payables stood at $2.6 million in 2022, then plummeted by 77.43% to $586000.0 in 2023, then crashed by 75.6% to $143000.0 in 2024, then plummeted by 1017.48% to -$1.3 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$1.3 million, $3.3 million, and $177000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.